Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Kymera Therapeutics Inc shares valued at $651,766 were sold by Esposito Pamela on Sep 17 ’24. At $48.28 per share, Esposito Pamela sold 13,500 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, PAMELA ESPOSITO purchased 13,500 shares, netting a total of over 654,480 in proceeds.
Before that, Albers Jeffrey W. had sold 5,000 shares from its account. In a trade valued at $245,508, the Director traded Kymera Therapeutics Inc shares for $49.10 each. Upon closing the transaction, the insider’s holdings decreased to 5,000 shares, worth approximately $0.0.
As published in their initiating research note from Stephens on November 18, 2024, Kymera Therapeutics Inc [KYMR] has been an Overweight and the price target has been revised to $65. As of August 26, 2024, Wolfe Research has increased its “Peer perform” rating to a “an Outperform” for KYMR. Earlier on April 22, 2024, Oppenheimer initiated its rating. Their recommendation was “an Outperform” for KYMR stock.
Analyzing KYMR Stock Performance
During the last five days, there has been a drop of approximately -5.30%. Over the course of the year, Kymera Therapeutics Inc shares have jumped approximately 70.90%. Shares of the company reached a 52-week high of $53.27 on 09/26/24 and a 52-week low of $22.35 on 01/04/24. A 50-day SMA is recorded $46.98, while a 200-day SMA reached $40.90. Nevertheless, trading volume fell to 0.51 million shares from 0.39 million shares the previous day.
Support And Resistance Levels for Kymera Therapeutics Inc (KYMR)
According to the 24-hour chart, there is a support level at 42.65, which, if violated, would cause prices to drop to 41.79. In the upper region, resistance lies at 44.59. The next price resistance is at 45.66. RSI (Relative Strength Index) is 40.68 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -3.41, which suggests the price will decrease in the coming days. Percent R is at 80.26%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
